MET and neoplasm: Since aberrant c-MET function plays an important role in the metastatic capacity, we examined the in vivo effect of the c-MET inhibitor SU11274 on primary tumor proliferation and liver colonization ability of the cetuximab resistant PE/CA-PJ15 and the cetuximab sensitive PJ41 HNSCC cells.